Anchen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ANCHEN PHARMS, and what generic and branded alternatives to ANCHEN PHARMS drugs are available?
ANCHEN PHARMS has twenty-seven approved drugs.
There are two tentative approvals on ANCHEN PHARMS drugs.
Drugs and US Patents for Anchen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anchen Pharms | LAMOTRIGINE | lamotrigine | TABLET, EXTENDED RELEASE;ORAL | 201374-003 | Dec 26, 2012 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anchen Pharms | DIVALPROEX SODIUM | divalproex sodium | TABLET, DELAYED RELEASE;ORAL | 078411-001 | Nov 3, 2008 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anchen Pharms | LUBIPROSTONE | lubiprostone | CAPSULE;ORAL | 201442-001 | Jun 27, 2022 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Anchen Pharms | POTASSIUM CHLORIDE | potassium chloride | CAPSULE, EXTENDED RELEASE;ORAL | 202886-002 | Dec 26, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.